Spencer R W, Copp L J, Bonaventura B, Tam T F, Liak T J, Billedeau R J, Krantz A
Biochem Biophys Res Commun. 1986 Nov 14;140(3):928-33. doi: 10.1016/0006-291x(86)90724-2.
A series of substituted 4H-3,1-benzoxazin-4-ones have been made and assayed as inhibitors of human leukocyte elastase (HLE) and other serine proteases. The benzoxazinones are kinetically competitive, alternate substrate inhibitors that inhibit by acylation and slow deacylation. Two structure-activity relationships have been found which are consistent with this mechanism. First, electron withdrawal at position 2 gives better inhibition (lower Ki values) because acylation rates are increased while deacylation is relatively unaffected. Second, benzoxazinones with methyl or ethyl substitution at position 5 are better inhibitors of HLE because the acyl enzymes formed from these compounds are 2,6-disubstituted benzoic acid esters and their deacylation is sterically hindered.
已经合成了一系列取代的4H-3,1-苯并恶嗪-4-酮,并作为人白细胞弹性蛋白酶(HLE)和其他丝氨酸蛋白酶的抑制剂进行了测定。苯并恶嗪酮是动力学竞争性的、交替底物抑制剂,通过酰化作用抑制并减缓脱酰化过程。发现了两种构效关系,这与该机制一致。首先,2位的吸电子基团能产生更好的抑制作用(更低的Ki值),因为酰化速率增加而脱酰化相对不受影响。其次,5位被甲基或乙基取代的苯并恶嗪酮是更好的HLE抑制剂,因为由这些化合物形成的酰基酶是2,6-二取代苯甲酸酯,其脱酰化受到空间位阻。